These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 21336863

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. More than 25 years of genetic studies of clozapine-induced agranulocytosis.
    de With SAJ, Pulit SL, Staal WG, Kahn RS, Ophoff RA.
    Pharmacogenomics J; 2017 Jul; 17(4):304-311. PubMed ID: 28418011
    [Abstract] [Full Text] [Related]

  • 5. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.
    Athanasiou MC, Dettling M, Cascorbi I, Mosyagin I, Salisbury BA, Pierz KA, Zou W, Whalen H, Malhotra AK, Lencz T, Gerson SL, Kane JM, Reed CR.
    J Clin Psychiatry; 2011 Apr; 72(4):458-63. PubMed ID: 20868635
    [Abstract] [Full Text] [Related]

  • 6. Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C.
    McKnight C, Guirgis H, Votolato N.
    Am J Psychiatry; 2011 Oct; 168(10):1120. PubMed ID: 21969051
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis.
    Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Müller DJ, Putkonen A, Repo-Tiihonen E, Hallikainen T, Yağcıoğlu AE, Tiihonen J, Kennedy JL, Meltzer HY.
    Mol Psychiatry; 2014 Apr; 19(4):403-5. PubMed ID: 23752246
    [No Abstract] [Full Text] [Related]

  • 10. How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?
    Verbelen M, Lewis CM.
    Pharmacogenomics; 2015 Apr; 16(9):915-7. PubMed ID: 26122865
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New findings in pharmacogenetics of schizophrenia.
    Zai CC, Tiwari AK, Zai GC, Maes MS, Kennedy JL.
    Curr Opin Psychiatry; 2018 May; 31(3):200-212. PubMed ID: 29528898
    [Abstract] [Full Text] [Related]

  • 13. Pharmacogenetics of response to antipsychotics in patients with schizophrenia.
    Arranz MJ, Rivera M, Munro JC.
    CNS Drugs; 2011 Nov 01; 25(11):933-69. PubMed ID: 22054119
    [Abstract] [Full Text] [Related]

  • 14. Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese Population.
    Saito T, Ikeda M, Mushiroda T, Ozeki T, Kondo K, Shimasaki A, Kawase K, Hashimoto S, Yamamori H, Yasuda Y, Fujimoto M, Ohi K, Takeda M, Kamatani Y, Numata S, Ohmori T, Ueno S, Makinodan M, Nishihata Y, Kubota M, Kimura T, Kanahara N, Hashimoto N, Fujita K, Nemoto K, Fukao T, Suwa T, Noda T, Yada Y, Takaki M, Kida N, Otsuru T, Murakami M, Takahashi A, Kubo M, Hashimoto R, Iwata N.
    Biol Psychiatry; 2016 Oct 15; 80(8):636-42. PubMed ID: 26876947
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort).
    Ter Hark SE, Jamain S, Schijven D, Lin BD, Bakker MK, Boland-Auge A, Deleuze JF, Troudet R, Malhotra AK, Gülöksüz S, Vinkers CH, Ebdrup BH, Kahn RS, Leboyer M, Luykx JJ.
    J Psychopharmacol; 2020 May 15; 34(5):524-531. PubMed ID: 32126890
    [Abstract] [Full Text] [Related]

  • 17. Mitchell B. Balter Award. Human leukocyte antigen-A1 predicts a good therapeutic response to clozapine with a low risk of agranulocytosis in patients with schizophrenia.
    Lahdelma L, Ahokas A, Andersson LC, Suvisaari J, Hovatta I, Huttunen MO, Koskimies S.
    J Clin Psychopharmacol; 2001 Feb 15; 21(1):4-7. PubMed ID: 11199946
    [Abstract] [Full Text] [Related]

  • 18. Medical complications of new antipsychotic drugs.
    Umbricht D, Kane JM.
    Schizophr Bull; 1996 Feb 15; 22(3):475-83. PubMed ID: 8873298
    [Abstract] [Full Text] [Related]

  • 19. Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances.
    Kao AC, Rojnic Kuzman M, Tiwari AK, Zivkovic MV, Chowdhury NI, Medved V, Kekin I, Zai CC, Lieberman JA, Meltzer HY, Bozina T, Bozina N, Kennedy JL, Sertic J, Müller DJ.
    J Psychiatr Res; 2014 Jul 15; 54():36-42. PubMed ID: 24725652
    [Abstract] [Full Text] [Related]

  • 20. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL.
    J Clin Psychiatry; 2001 Jul 15; 62 Suppl 23():45-66. PubMed ID: 11603885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.